Transient expansion of vestibular schwannoma following stereotactic radiosurgery

被引:121
|
作者
Nagano, Osamu [1 ]
Higuchi, Yoshinori
Serizawa, Toru [3 ]
Ono, Junichi [2 ]
Matsuda, Shinji [4 ]
Yamakami, Iwao
Saeki, Naokatsu
机构
[1] Chiba Univ, Grad Sch Med, Dept Neurol Surg, Chuou Ku, Chiba 2600856, Japan
[2] Chiba Cardiovasc Ctr, Dept Neurosurg, Ichihara, Chiba, Japan
[3] Chiba Cardiovasc Ctr, Gamma Knife House, Ichihara, Chiba, Japan
[4] Chiba Cardiovasc Ctr, Dept Neurol, Ichihara, Chiba, Japan
关键词
facial nerve function; Gamma Knife surgery; stereotactic radiosurgery; transient tumor expansion; trigeminal nerve dysesthesia; vestibular schwannoma;
D O I
10.3171/JNS/2008/109/11/0811
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. The authors prospectively analyzed volume changes in vestibular schwannomas (VSs) after stereotactic radiosurgery. Methods. One hundred Consecutive patients with unilateral VS treated with Gamma Knife Surgery (GKS) at Chiba Cardiovascular Center between 1998 and 2006 were analyzed in this study. For each lesion the Gd-enhanced volume was measured serially every 3 months in the 1st year, then every 6 months thereafter, using volumetric software. The frequency and degree of transient tumor expansion were documented and possible prognostic factors were analyzed. Concurrently, neurological deterioration involving trigeminal, facial, and cochlear nerve functions were also assessed. Results. The mean observation period was 65 months (range 25-100 months). There were 32 men and 68 women whose mean age was 59.1 years (range 29-80 years). Tumor volumes at GKS averaged 2.7 cm(3) (range 0.1-13.2 C 113), and the lesions were irradiated at the mean 52.2% isodose line for the tumor margin (range 50-67%), with a mean dose of 12.2 Gy (range 10.5-13 Gy) at the periphery. The tumor Volume was increased by 23% at 3 months and 27% at 6 months. Tumors shrank to their initial size over a mean period of 12 months. The maximum volume increase was < 10% (no significant increase) in 26 patients, 10-30% in 23, 30-50% in 22, 50-100% in 16, and > 100% in 13. The peak tumor expansion averaged 47% (range 0-613%). A high-dose (>= 3.5 Gy/min) treatment appears to be the greatest risk factor for transient tumor expansion, although the difference did not reach statistical significance. Transient facial palsy and facial dysesthesia correlated strongly with tumor expansion, but only half of the hearing loss was coincident with this phenomenon. Conclusions. Transient expansion of VSs after GKS was found to be much more frequent than previously reported, strongly Suggesting a correlation with deterioration of facial and trigeminal nerve functions.
引用
收藏
页码:811 / 816
页数:6
相关论文
共 50 条
  • [21] Reported Hearing Outcome Measures Following Stereotactic Radiosurgery for Vestibular Schwannoma: A Scoping Review
    Almufarrij, Ibrahim
    Hannan, Cathal John
    King, Andrew Thomas
    Vail, Andy
    Heal, Calvin
    Whitfield, Gillian
    Pathmanaban, Omar Nathan
    Lloyd, Simon K. K.
    Munro, Kevin J. J.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2024, 85 (02) : 123 - 130
  • [22] Vestibular schwannoma associated with neurofibromatosis type 2: Clinical course following stereotactic radiosurgery
    Kim, Junhyung
    Byeon, Yukyeng
    Song, Sang Woo
    Cho, Young Hyun
    Hong, Chang-Ki
    Hong, Seok Ho
    Kim, Jeong Hoon
    Lee, Do Heui
    Park, Ji Eun
    Kim, Ho Sung
    Kim, Young-Hoon
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Associations of Microvascular Risk Factors with Sporadic Vestibular Schwannoma Outcomes Following Stereotactic Radiosurgery
    Dornhoffer, James R.
    Babajanian, Eric E.
    Khandalavala, Karl R.
    Marinelli, John P.
    Daher, Ghazal S.
    Lohse, Christine M.
    Link, Michael J.
    Carlson, Matthew L.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2025, 172 (03) : 967 - 973
  • [24] Tumor pseudoprogression following radiosurgery for vestibular schwannoma
    Hayhurst, Caroline
    Zadeh, Gelareh
    NEURO-ONCOLOGY, 2012, 14 (01) : 87 - 92
  • [25] Impact of Cochlear Dose on Hearing Preservation following Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy for the Treatment of Vestibular Schwannoma
    Chung, Lawrance K.
    Ung, Nolan
    Sheppard, John P.
    Thien Nguyen
    Lagman, Carlito
    Choy, Winward
    Tenn, Stephen
    Pouratian, Nader
    Lee, Percy
    Kaprealian, Tania
    Selch, Michael
    De Salles, Antonio
    Gopen, Quinton
    Yang, Isaac
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2018, 79 (04) : 335 - 342
  • [26] PATTERNS OF TUMOR RESPONSE AFTER STEREOTACTIC RADIOSURGERY FOR VESTIBULAR SCHWANNOMA
    Kabarriti, Rafi
    Mourad, Waleed F.
    Mejia, Diana Molinares
    Glanzman, Jonathan
    Patel, Shyamal
    Young, Rebekah
    Bernstein, Michael
    Hong, Linda
    Fox, Jana
    LaSala, Patrick
    Kalnicki, Shalom
    Garg, Madhur
    NEURO-ONCOLOGY, 2013, 15 : 182 - 183
  • [27] Patterns of tumor response after stereotactic radiosurgery for vestibular schwannoma
    Kabarriti, R.
    Mourad, W. F.
    Mejia, D. Molinares
    Glanzman, J.
    Patel, S.
    Hong, L.
    Fox, J.
    LaSala, P.
    Kalnicki, S.
    Garg, M. K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S227 - S227
  • [28] Koos grade IV vestibular schwannoma treated with stereotactic radiosurgery
    Sloane, Dayna C.
    Hand, Rob
    Anderson, Douglas E.
    JOURNAL OF NEUROSURGERY, 2023, 139 (02)
  • [29] Stereotactic radiosurgery for recurrent vestibular schwannoma after previous resection
    Huang, Marshall J.
    Kano, Hideyuki
    Mousavi, Seyed H.
    Niranjan, Ajay
    Monaco, Edward A., III
    Arai, Yoshio
    Flickinger, John C.
    Lunsford, L. Dade
    JOURNAL OF NEUROSURGERY, 2017, 126 (05) : 1506 - 1513
  • [30] Comparing costs of microsurgical resection and stereotactic radiosurgery for vestibular schwannoma
    Schnurman, Zane
    Golfinos, John G.
    Epstein, David
    Friedmann, David R.
    Roland, J. Thomas, Jr.
    Kondziolka, Douglas
    JOURNAL OF NEUROSURGERY, 2019, 131 (05) : 1395 - 1404